This site uses cookies to ensure the best viewing experience for our readers. Read more about it Got it

Startup Uses Business Intelligence Toolkit to Help Patients Improve Healthcare Choices

Israel-based Medint collects and analyzes information from medical websites, social platforms, blogs, and forums to help patients make informed decisions

Anat Danieli 15:4320.06.18

Tel Aviv-based Medint Medical Intelligence Ltd. wants to help patients with cancer and chronic illnesses make informed medical decisions, and it uses methods borrowed from the world of business intelligence to do so.

 

For daily updates, subscribe to our newsletter by clicking here.

 

"Imagine your father was diagnosed with advanced cancer," Medint CEO and co-founder Tanya Attias said Tuesday, speaking at an entrepreneurship conference held by Calcalist at Labs, a co-working space in Tel Aviv. "Who are the three doctors with the most experience treating similar cases? Which relevant clinical trials are currently open to him? What questions do you not know to ask his doctor, and what life changes could increase his odds of recovery?"

 

Medint CEO and co-founder Tanya Attias. Photo: Orel Cohen Medint CEO and co-founder Tanya Attias. Photo: Orel Cohen

 

 

In today's world, Ms. Attias said, information is more accessible than ever, but at critical moments, patients rarely have all the relevant data.

 

Founded in 2016, Medint collects and analyzes information from medical websites, social platforms, blogs, and forums, and also works with a network of medical researchers. Ms. Attias previously worked as a cyber intelligence consultant and analyst, and Medint's team uses intelligence gathering methods as well as data science technology to provide patients with personalized insights, she explained.

 

Success is measured by the ability to present a new option to a patient where there was none before, Ms. Attias said.

 

According to its website, Medint's services cost $1,000-$2,500, depending on the complexity of the case.
Cancel Send
    To all comments